Related Experiment Video
Updated: Jul 17, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
MAVS integrates glucose metabolism and RIG-I-like receptor signaling
Qiao-Qiao He1, Yu Huang1, Longyu Nie1
1State Key Laboratory of Virology, Modern Virology Research Center, Frontier Science Center for Immunology and Metabolism, College of Life Sciences, Wuhan University, Wuhan, 430072, China.
Abstract:
MAVS is an adapter protein involved in RIG-I-like receptor (RLR) signaling in mitochondria, peroxisomes, and mitochondria-associated ER membranes (MAMs). However, the role of MAVS in glucose metabolism and RLR signaling cross-regulation and how these signaling pathways are coordinated among these organelles have not been defined. This study reports that RLR action drives a switch from glycolysis to the pentose phosphate pathway (PPP) and the hexosamine biosynthesis pathway (HBP) through MAVS. We show that peroxisomal MAVS is responsible for glucose flux shift into PPP and type III interferon (IFN) expression, whereas MAMs-located MAVS is responsible for glucose flux shift into HBP and type I IFN expression. Mechanistically, peroxisomal MAVS interacts with G6PD and the MAVS signalosome forms at peroxisomes by recruiting TNF receptor-associated factor 6 (TRAF6) and interferon regulatory factor 1 (IRF1). By contrast, MAMs-located MAVS interact with glutamine-fructose-6-phosphate transaminase, and the MAVS signalosome forms at MAMs by recruiting TRAF6 and TRAF2. Our findings suggest that MAVS mediates the interaction of RLR signaling and glucose metabolism.
Insights
Mitochondrial antiviral signaling (MAVS) protein regulates glucose metabolism by shifting pathways like glycolysis to the pentose phosphate pathway (PPP) and hexosamine biosynthesis pathway (HBP). Peroxisomal and MAMs-associated MAVS have distinct roles in this metabolic reprogramming and interferon signaling.
Area of Science:
- Immunology
- Cell Biology
- Metabolic Pathways
Background:
- Mitochondrial antiviral signaling (MAVS) protein is crucial for RIG-I-like receptor (RLR) signaling.
- The precise roles of MAVS in glucose metabolism and its cross-regulation with RLR signaling across organelles remain unclear.
- Understanding how these pathways are coordinated is essential for deciphering cellular defense mechanisms.
Purpose of the Study:
- To investigate the role of MAVS in glucose metabolism.
- To elucidate the cross-regulation between RLR signaling and glucose metabolism.
- To define the organelle-specific functions of MAVS in coordinating these pathways.
Main Methods:
- Investigated MAVS localization and function in peroxisomes and mitochondria-associated ER membranes (MAMs).
- Analyzed glucose flux shifts using metabolic pathway tracing.
- Identified protein-protein interactions within MAVS signalosomes using co-immunoprecipitation and Western blotting.
Main Results:
- RLR activation via MAVS promotes a metabolic switch from glycolysis to the pentose phosphate pathway (PPP) and hexosamine biosynthesis pathway (HBP).
- Peroxisomal MAVS directs glucose flux to PPP and induces type III interferon expression.
- MAMs-associated MAVS directs glucose flux to HBP and induces type I interferon expression, involving specific protein interactions like G6PD and glutamine-fructose-6-phosphate transaminase.
Conclusions:
- MAVS acts as a critical mediator linking RLR signaling with glucose metabolism.
- Organelle-specific localization of MAVS dictates distinct metabolic and immune signaling outcomes.
- This study reveals a novel mechanism of metabolic reprogramming orchestrated by MAVS during innate immune responses.
More Related Videos
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Insulin: The Receptor and Signaling Pathways
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Regulation of Metabolism

